Akoya Biosciences Inc (AKYA)
2.66
+0.04
(+1.53%)
USD |
NASDAQ |
Jan 08, 16:00
3.36
+0.70
(+26.32%)
Pre-Market: 09:22
Akoya Biosciences SG&A Expense (Quarterly): 14.67M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Bruker Corp | 238.50M |
| Azenta Inc | 72.01M |
| Harvard Bioscience Inc | 10.56M |
| Bionano Genomics Inc | 9.464M |
| Singular Genomics Systems Inc | 8.202M |